Ipsoflog (Piroxicam)

Piroxicam works by non‑selectively blocking the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain signaling, and fever responses in the affected tissues.

The specific dose of Ipsoflog is determined by the prescribing healthcare professional based on the patient’s condition, severity, age, renal and hepatic function, and other individual factors. Patients should follow the exact regimen provided by their prescriber and not adjust the dose on their own.

The safety of piroxicam in pregnancy and lactation has not been definitively established, and it is generally classified as contraindicated or used only when the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To request Ipsoflog, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ipsoflog (piroxicam) has a relatively long half‑life, allowing once‑daily dosing in many cases, which can be convenient compared with shorter‑acting NSAIDs such as ibuprofen. However, its gastrointestinal and renal risk profile is similar to other non‑selective NSAIDs, so risk‑benefit assessment remains essential.

Ipsoflog should be stored at room temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, direct sunlight and excessive heat to maintain stability and potency throughout the shelf life.

Ipsoflog is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce mild gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it unless instructed otherwise.

The most serious adverse events linked to piroxicam include gastrointestinal ulceration or bleeding, severe hepatic injury, renal impairment, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if any signs of these conditions appear.

Ipsoflog is contraindicated in patients with known hypersensitivity to piroxicam or other NSAIDs, active peptic ulcer disease, severe hepatic or renal impairment, and those on anticoagulant therapy where bleeding risk is unacceptable. It should also be avoided in the third trimester of pregnancy.